Precigen PGEN
NASDAQ PGEN
$7.11 -0.03 (-0.49%)
As of: Sep 4, 2026 · 3:59 PM EDT

Precigen (PGEN) Gross Margin (QoQ) (2013 - 2026)

Analysis

Precigen (PGEN) Gross Margin (QoQ) (2013 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Precigen 2.53 Bn 2.53 Bn 52.17 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 590.00
Mar 31, 2026 2,396.00
Dec 31, 2025 46.00
Sep 30, 2025 9,215.00
Jun 30, 2025 -4,554.00
Mar 31, 2025 1,621.00
Dec 31, 2024 764.00
Sep 30, 2024 3,555.00
Jun 30, 2024 -4,048.00
Mar 31, 2024 965.00
Dec 31, 2023 87.00
Sep 30, 2023 -1,542.00
Jun 30, 2023 -1,354.00
Mar 31, 2023 -1,120.00
Dec 31, 2022 -6,187.00
Sep 30, 2022 5,278.00
Jun 30, 2022 -3,148.00
Mar 31, 2022 4,764.00
Dec 31, 2021 -4,926.00
Sep 30, 2021 -514.00